Skip to main content
NIH funding notice PAR-19-347

Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed)

Closed on March 23, 2021.

Posted
August 16, 2019
Close date
March 23, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $77,834 in first-year total cost, median $77,834.

Most frequent study sections

  1. Cellular and Molecular Immunology - B Study Section[CMIB]1

Most frequent institutions

  1. UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON1
Competing awards under PAR-19-347 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Impact of probiotic-mediated adenosine metabolism in regulating immune dysfunction.1R03AI153725-01LIU, YUYINGUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX$77,834CMIB

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.